Sun Pharma Advanced Research Co P/E Ratio
Current P/E Ratio
4.03
Low Valuation
Very Low - Potentially undervalued or facing challenges
Sun Pharma Advanced Research Co (SPARC) P/E ratio is 4.03 (Low), EPS (TTM) ₹47.86, current price ₹193.92 on NSE — Very Low - Potentially undervalued or facing challenges. Also explore SPARC stock price history to track price trends across different timeframes.
Current Valuation Metrics
P/E Ratio
4.03
Current Price
₹193.92
EPS (TTM)
₹47.86
Exchange
NSE
Valuation Signal
Signal
Undervalued
Sector Context
Sector Average
57.06
Sector Median
32.06
Sector Rank
#5 of 199
Sector Percentile
2.5%
Earnings Breakdown (TTM)
TTM EPS
₹49.45
Mar 2026
₹54.27
Jun 2026
₹-0.64
SPARC P/E Ratio — Valuation Signal & Historical Context
Sun Pharma Advanced Research Co P/E 4.03 — signal: Undervalued.
- Stock appears undervalued with PE of 4.03, suggesting potential buying opportunity
- Trading at discount to sector average PE of 57.06
SPARC vs Healthcare Peers — P/E Ratio Comparison
Sun Pharma Advanced Research Co P/E 4.03 vs Healthcare average 57.06, median 32.06 — range 1.99–747.21.
Sector Average
57.06
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
199
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |
| Royal Sense | ROYAL | 7.11 | ₹50 | Low |